Japan Could Become The First Country To Eradicate HIV

Updated Mar 7, 2025 | 05:00 PM IST

SummaryThe idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.
Japan Could Become The First Country To Eradicate HIV

Credits: Canva

Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.

What Is The Role Of Preventative HIV Medicines?

Gilead's have two key drugs, Truvada and lenacapavir. These two are playing a crucial role in prevention. Truvada is taken as a daily pill, while lenacapavir requires two injections per year. It can make the virus undetectable in infected individuals and prevent transmission to those who are not infected yet. In trials, lenacapavir showed 100% efficacy in preventing HIV infections. This is why it is describe as "almost a vaccine".

In 2024, Japan also approved Truvada for HIV prevention, but the country has yet to approve lenacapavir for the same. Until now, people in Japan had been importing generic versions of Truvada or purchasing it from clinics that source it from overseas.

HIV In Japan

Up until now, Japan reported around 25,000 HIV infections, whereas 669 new cases were reported in 2023. For seven consecutive years, the number of new infections remained under 1,000. The downward trend thus shows that the virus has been controlled, however, getting to zero new infections remains the ultimate goal.

Brysting too acknowledged that simply having effective drug is not enough. What is important is to have a proper implementation, access and healthcare support to make sure that these treatments are widely available and effective.

What Are The Challenges In Implementation?

The biggest challenges is testing rates. There is a need to increase testing rates. At this very moment, around 86% people infective with Japan have been tested, but the goal is to increase it up to 95%, with an ideal goal of 100%. Without widespread testing, many infected people may not even know that they are infected and it could transmit the virus.

Another measure issue is the cost of preventative medication. While Japan's health insurance covers treatments for diseases, it does not cover preventative drugs. Those who purchase Truvada for prevention, pay around $470 per month. Some clinics in Tokyo offer generic alternatives too, which is cheaper, but they are not ideal.

Better Healthcare Support

Brysting expressed concern that individuals importing medications might not be consulting doctors regularly, which is essential for monitoring HIV status and overall health. Truvada users need to be tested for HIV initially and every three months, along with screenings for other infections and kidney function checks. Without proper medical supervision, there is a risk of misuse and inadequate protection.

Gilead is in discussions with Japanese authorities to improve access and insurance coverage for Truvada, and progress is being made. Japan has shown efficiency in approving critical medicines, as seen during the COVID-19 pandemic when Gilead’s remdesivir was approved in just three days.

What Is The Way Ahead?

Gilead at this moment is not only focused on HIV and hepatitis C, but also expanding into oncology with innovative treatments like CAR-T cell therapy, which strengthens a patient's immune system to fight cancer.

However, Japan’s strict approval processes can slow down drug availability. Phase 3 clinical trials often need to be conducted within the country, and Japan tends to approve medicines much later than other regions. For instance, Truvada was approved for prevention in Japan 12 years after the U.S. and nearly 20 years after its approval for treatment. inancial factors also play a role. The Japanese government adjusts drug prices annually, often reducing them, which can make long-term investment challenging for pharmaceutical companies.

End of Article

Bean-Based Chewing Gum Cuts HPV Levels By Up To 93%: Could It Help Prevent Cancer?

Updated Nov 17, 2026 | 12:00 AM IST

SummaryResearchers found that extracts of the bean-based gum reduced HPV levels by up to 93% in oral samples from patients with head and neck cancer.
Bean-Based Chewing Gum Cuts HPV Levels By Up To 93%: Could It Help Prevent Cancer?

Credit: iStock

Could chewing gum one day help fight cancer? Researchers at the University of Pennsylvania in the US have developed an experimental gum made from lablab beans, also known as Indian beans, that targets human papillomavirus (HPV) and harmful oral bacteria associated with head and neck cancer.

In laboratory tests using oral samples from cancer patients, extracts of the gum reduced HPV levels by up to 93%. An enhanced version also reduced two harmful bacterial species to nearly undetectable levels without affecting the beneficial bacteria tested.

How Does The Bean-Based Chewing Gum Work?

The experimental gum builds on the team's earlier research into lablab beans. It contains FRIL, a naturally occurring plant protein with antiviral properties.

Researchers tested gum extracts against microorganisms in oral samples collected from patients with head and neck cancer.

The results published in Scientific Reports journal showed:

  • HPV levels decreased by 93% in saliva samples.
  • HPV levels decreased by 80% in oral rinse samples.

The researchers also developed an enhanced version containing protegrin, an antimicrobial peptide. Peptides are short chains of amino acids, the building blocks of proteins.

A single dose of the enhanced gum extract reduced two targeted bacterial species, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn), to nearly undetectable levels.

Also read: HPV Vaccines Can Prevent Head And Neck Cancers In Men, Says Study

Harmful Bacteria Reduced Without Affecting Beneficial Microbes

The experimental formulation selectively targeted harmful bacteria while leaving the beneficial bacterial populations examined in the study largely unaffected.

The oral microbiome, which consists of microorganisms living inside the mouth, plays an important role in maintaining oral health.

Cancer treatments such as radiation therapy can disrupt this microbial balance, reducing beneficial bacteria and encouraging the growth of potentially harmful microorganisms, including Candida albicans, a type of yeast.

The researchers suggest that selectively targeting harmful microbes while preserving beneficial ones could be particularly useful for patients undergoing cancer treatment.

Read More: Russia's mRNA Cancer Vaccine: First Patient With Melanoma Completes Treatment, Shows No New Tumours

Could The Chewing Gum Help Prevent Cancer?

The researchers believe the findings warrant further investigation through human clinical trials. They envision the technology potentially being used alongside existing cancer treatments or as a preventive approach to limit infections.

"Lip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022," Daniell said.

He said the findings support advancing these therapies into clinical trials as additional treatments or as prophylaxis to prevent infection and transmission.

Prophylaxis refers to measures taken to prevent a disease or infection before it occurs.

The plant-based technology could also offer a potentially affordable way to deliver protective proteins directly into the mouth.

However, the findings should be interpreted cautiously. The researchers tested gum extracts on patient samples under laboratory conditions. They have not established whether chewing the gum produces the same results in people or whether reducing these microorganisms can prevent cancer or improve treatment outcomes.

Human clinical trials will be needed to establish its safety and effectiveness. For now, the bean-based gum remains experimental and is not a proven cancer-prevention or treatment option.

End of Article

Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO

Updated Nov 16, 2026 | 10:00 PM IST

SummaryThe WHO warns that despite more countries adopting national AMR action plans, gaps in funding, infection prevention, laboratory capacity and surveillance are putting global 2030 targets at risk.
Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO

Credit: iStock

With one in six laboratory-confirmed bacterial infections worldwide already resistant to antibiotics, drug-resistant infections could contribute to more than 39 million deaths by 2050 if current trends persist, according to the World Health Organization (WHO).

Speaking at the virtual 6th Annual Global Media Forum on AMR, WHO officials warned that countries are not doing enough to tackle antimicrobial resistance (AMR), despite growing commitments. They also presented findings from the latest joint survey by WHO, the United Nations Environment Programme, the World Organisation for Animal Health and the Food and Agriculture Organization.

Although more countries have adopted national action plans to combat AMR, most have failed to translate these commitments into funded and implemented programmes. As a result, the world remains off track to meet key 2030 targets.

Of the 183 countries surveyed, 173 reported having a national action plan, up from 79 in 2017. However, only 42 said their plans were financed and implemented.

What Is Antimicrobial Resistance?

Also read: Over One In Four Americans Lied To Get Antibiotics For Children: Why It Can Be Dangerous

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat them. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.

Antibiotic resistance is a form of AMR that specifically involves bacteria becoming resistant to antibiotics. Misuse and overuse of these medicines accelerate the problem.

At the 2024 United Nations General Assembly, countries agreed on a series of targets to tackle AMR by 2030. However, experts warn that the growing threat could undermine decades of medical progress.

"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," Jean-Pierre Nyemazi, acting director of WHO's AMR department, said. The development of new antibiotics is also failing to keep pace with the spread of resistance, he added, Reuters reported.

"Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should," Nyemazi said at the forum.

In 2021 alone, AMR was directly responsible for more than one million deaths and associated with approximately 4.7 million others, according to WHO figures.

What Did The WHO Survey Show?

The 2026 survey highlighted major gaps in infection prevention, a key measure for reducing the need for antibiotics.

The WHO reported that 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018. However, only 69 countries, or 38%, have implemented these programmes nationwide, well below the 2030 target of 90%.

Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?

Laboratory capacity also remains limited. While 131 countries reported having national reference laboratories capable of testing antibiotic resistance in common bacteria, only 66 could test for both bacterial and fungal resistance. Countries have agreed to ensure that 80% have these capabilities by 2030.

The WHO also released two toolkits to help countries strengthen diagnostic capacity, covering essential tests and laboratory procedures.

Surveillance has improved, with 113 countries now monitoring antibiotic use and 109 tracking antimicrobial resistance, compared with 65 and 39, respectively, in 2017.

However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO said combining these datasets is essential to understand how antibiotic consumption drives resistance and to guide efforts to contain it.

Why Is Taking Unnecessary Antibiotics Dangerous?

Antibiotics treat bacterial infections but do not work against viral infections, which commonly cause cold- and flu-like symptoms. Unnecessary use can also expose patients to side effects and contribute to antimicrobial resistance.

As per the WHO, resistance exists across 22 different antibiotics—the common drugs used to treat everyday illnesses, such as:

  • Urinary tract infections (UTIs)
  • Stomach and intestinal infections
  • Dangerous blood infections
  • The sexually transmitted disease gonorrhoea

When bacteria develop resistance, infections become harder to treat, increasing the risk of complications and limiting available treatment options.

(With inputs from agencies)

End of Article

NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Updated Nov 16, 2026 | 07:00 PM IST

SummaryNASA scientists warn that the 2026–27 El Niño could rival or surpass the historic 1997–98 event. The potentially record-breaking climate phenomenon could intensify heatwaves, worsen air quality, alter infectious disease risks and increase food insecurity, raising concerns about its global public health impact.
NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Credit: iStock

NASA scientists warn that the developing 2026–27 El Niño could rival or surpass the powerful 1997–98 event, which triggered severe droughts, fires and flooding worldwide.

The new findings amid climate deliberations taking place at the COP31 in Turkiye.

Using 35 years of satellite observations, researchers are comparing the current event with previous strong El Niños. The climate phenomenon, marked by warmer-than-average sea-surface temperatures in the central and eastern equatorial Pacific, can disrupt weather patterns worldwide and raise global temperatures.

The 1997–98 and 2015–16 events were among the strongest on record, bringing fires to Indonesia and the Amazon, droughts in southern Africa, and heavy rainfall in Southern California.

How Does The 2026 El Niño Compare With The 1997 Event?

Also read: El Niño Could Worsen Dengue, Malaria And Heat Illness: Why WHO Declared A Health Emergency

Satellite altimetry measures changes in ocean surface height, helping scientists track heat accumulation in the Pacific. Warmer seawater expands, raising sea levels.

"What's unique about altimetry is that we have a 35-year record from nearly identical satellites flying almost the same ground track, with each mission overlapping the next," said Josh Willis, project scientist for sea level missions at NASA's Jet Propulsion Laboratory (JPL). "That lets us look back in time and compare this El Niño to what happened in 1997. And right now, this one is on track to be even bigger."

NASA's October measurements show similarities between the two events, including lower sea levels in the western Pacific, higher levels in the east and unusually warm water extending towards South America.

These patterns raise the possibility of similar weather effects, including substantial rainfall across California and the southern United States this winter.

Could The 2026–27 El Niño Become One Of The Strongest On Record?

Read More: Climate Crisis Is A Health Crisis: Just 6 Actions Could Save 1.6 Million Lives, Says WHO

NOAA's October 8 outlook estimated an 83% chance of strong to very strong El Niño conditions during the first three months of 2027.

On November 12, its Climate Prediction Center classified the event as "very strong", the highest of four intensity categories. Only three other events since 1950 have reached this level: 1982–83, 1997–98 and 2015–16.

However, El Niño's effects vary by region and do not guarantee the same weather extremes everywhere.

How Could The Super El Niño Affect Your Health?

The World Meteorological Organization (WMO) warns that El Niño could amplify climate change-related health risks, including:

  • Extreme heat: More intense heatwaves could increase heat-related illnesses and deaths.
  • Poor air quality: Wildfires could expose more people to smoke and pollution.
  • Infectious diseases: Changing weather patterns could alter the risk of dengue, malaria and cholera.
  • Food insecurity: Disrupted agriculture could worsen malnutrition and water shortages.
  • Extreme weather: Floods and storms could increase injuries, deaths and pressure on healthcare systems.

El Niño Could Push 49 Million More People Into Acute Hunger

A World Food Programme (WFP) analysis published in October projected that El Niño could push 49 million additional people into acute food insecurity by the end of 2027, taking the global total from 225 million to 274 million.

At least 45 countries could experience worsening food insecurity, particularly communities dependent on rain-fed agriculture. WFP warns that the effects could persist through 2027 and into early 2028.

End of Article